Oral bisphosphonates and risk of atrial fibrillation and flutter in women: a self-controlled case-series safety analysis
about
Does design matter? Systematic evaluation of the impact of analytical choices on effect estimates in observational studiesBisphosphonates and risk of atrial fibrillation: a meta-analysis.A self-controlled case series to assess the effectiveness of beta blockers for heart failure in reducing hospitalisations in the elderly.Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis.Defining disease phenotypes using national linked electronic health records: a case study of atrial fibrillation.Atrial fibrillation and the use of oral bisphosphonates.Predictors of incident atrial fibrillation and influence of medications: a retrospective case-control study.Intravenous bisphosphonate therapy and atrial fibrillation/flutter risk in cancer patients: a nationwide cohort study.Efficacy of zoledronic acid in treatment of osteoporosis in men and women-a meta-analysis.Alendronate and atrial fibrillation: a meta-analysis of randomized placebo-controlled clinical trials.Use of the self-controlled case series method in drug safety assessmentAtrial fibrillation and bisphosphonate therapy.Clinical strategies to address patients' concerns in osteoporosis management with bisphosphonates.Safety of long-term bisphosphonate therapy for the management of osteoporosis.Heart failure as a risk factor for osteoporosis and fractures.Long-term risks of bisphosphonate therapy.Risks and Benefits of Bisphosphonate Therapies.The effects of zoledronic acid on ECG: a prospective study on patients with bone metastatic cancer.Arrhythmias during and after zoledronic acid infusion patients with bone metastasis.Self-controlled case series and misclassification bias induced by case selection from administrative hospital databases: application to febrile convulsions in pediatric vaccine pharmacoepidemiology.Oral bisphosphonates and risk of ischemic stroke: a case-control study.Zoledronic acid and atrial fibrillation in cancer patients.Multiple self-controlled case series for large-scale longitudinal observational databases.
P2860
Q24288975-7E0C45FC-FFA8-43C2-89F4-36E5E75BC4D2Q33873740-C4B6184A-5012-445B-BAD6-73A8E3C74299Q33962657-836D3BBA-5A82-4659-9E91-307D35376823Q34018048-6E81CE35-9FC2-498E-8A1C-43B61B5B579BQ34450233-71E019F5-270E-4E0E-8CD5-87CD1D22781FQ34764869-E49E525C-DE0C-45CD-B282-3883DA782ADFQ35012268-9A04E792-EB44-4CFC-8D65-054042FF1DFEQ35263110-18938F39-2BE8-4902-B135-555EFAE25EC4Q35643754-F6ACB11B-5BAA-4191-BD94-FAA594E15E00Q35644059-E1964C4F-14A8-4DC8-9773-9BF66C977D39Q36204221-5DD6D625-C46F-4733-B1D9-22356E406C5BQ37679127-8310ECD1-2A6F-498C-9239-67B58590F983Q37862933-3665E084-EC63-449E-907F-45C4EE07B974Q37866764-6AA9C4D8-C054-45ED-BE5C-C866E8ABC9AAQ38036949-F27E660C-32AF-467D-B5C9-326F4AA0DC9EQ38244171-805CD754-F4A0-422E-9C61-33729087D718Q38533828-B462B55D-4C0F-4BD6-8B54-B539A20F658CQ40984313-69130E20-E902-470C-8352-9D34A82693CBQ42438761-DBE6D159-E55C-4882-BF00-48CAB0784FACQ43848105-03B33B31-EF6B-46BC-9855-7992A12121D6Q44216787-FD0344FC-FCB2-4E6D-951D-14F2F1972532Q51573753-1CF680C2-CFDE-4D5D-8C97-91C2EE71027DQ53127939-E0493831-E9E2-429F-90DF-B4A57C868C59
P2860
Oral bisphosphonates and risk of atrial fibrillation and flutter in women: a self-controlled case-series safety analysis
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Oral bisphosphonates and risk ...... ed case-series safety analysis
@ast
Oral bisphosphonates and risk ...... ed case-series safety analysis
@en
type
label
Oral bisphosphonates and risk ...... ed case-series safety analysis
@ast
Oral bisphosphonates and risk ...... ed case-series safety analysis
@en
prefLabel
Oral bisphosphonates and risk ...... ed case-series safety analysis
@ast
Oral bisphosphonates and risk ...... ed case-series safety analysis
@en
P2093
P2860
P1433
P1476
Oral bisphosphonates and risk ...... ed case-series safety analysis
@en
P2093
Anthony Grosso
Aroon Hingorani
Ian Douglas
Raymond MacAllister
P2860
P356
10.1371/JOURNAL.PONE.0004720
P407
P577
2009-03-06T00:00:00Z